|
00 CANCELLED EVENTS
|
00 DELAYED EVENTS
|
|
00 DIGITALISED EVENTS
|
00 AS PLANNED EVENTS
|
People with hypertension were twice as likely to take medicine regularly when offered cash rewards, but that didn't improve their blood pressure.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
Policy experts Alice Valder Curran and Elizabeth Jungman of Hogan Lovells weigh in on Trump's MFN deals, FDA vouchers, and the government shutdown.
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 welcomes project leaders, procurement speciali
The transaction delivers total liquidity of $240 million, making it one of the largest employee-centric liquidity events in the industry.
